This compound is primarily utilized in the field of medicinal chemistry and drug development. Its structure suggests potential applications as a protease inhibitor, particularly in targeting enzymes involved in disease pathways such as viral infections or cancer. Researchers explore its use in designing small molecule therapeutics due to its ability to interact with specific protein targets. Additionally, its benzamide and benzylcarbamoyl groups make it a candidate for modulating biological processes, potentially leading to the development of novel treatments for complex diseases. Its application is often studied in preclinical settings to evaluate efficacy and safety before advancing to clinical trials.